• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内血栓形成的糖蛋白VI依赖性和非依赖性途径。

Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo.

作者信息

Dubois Christophe, Panicot-Dubois Laurence, Merrill-Skoloff Glenn, Furie Bruce, Furie Barbara C

机构信息

Division of Hemostasis and Thrombosis, Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, 840 Memorial Drive, Cambridge, MA 02139, USA.

出版信息

Blood. 2006 May 15;107(10):3902-6. doi: 10.1182/blood-2005-09-3687. Epub 2006 Feb 2.

DOI:10.1182/blood-2005-09-3687
PMID:16455953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1895285/
Abstract

The role of the collagen receptor glycoprotein VI (GPVI) in arteriolar thrombus formation was studied in FcRgamma-null mice (FcRgamma(-/-)) lacking platelet surface GPVI. Thrombi were induced with severe or mild FeCl(3) injury. Collagen exposure was significantly delayed and diminished in mild compared with severe FeCl(3) injury. Times to initial thrombus formation and vessel occlusion were delayed in FcRgamma(-/-) compared with wild-type mice after severe injury. Platelet accumulation in wild-type mice was decreased after mild compared with severe injury. However, there was little difference between platelet accumulation after severe or mild injury in FcRgamma(-/-). These data indicate a significant role for GPVI in FeCl(3)-induced thrombus formation. Pretreatment of wild-type mice with lepirudin further impaired mild FeCl(3)-induced thrombus formation, demonstrating a role for thrombin. Laser-induced thrombus formation in wild-type and FcRgamma(-/-) was comparable. Collagen exposure to circulating blood was undetectable after laser injury. Normalized for thrombus size, thrombus-associated tissue factor was 5-fold higher in laser-induced thrombi than in severe FeCl(3)-induced thrombi. Thus, platelet activation by thrombin appears to be more important after laser injury than platelet activation by GPVI-collagen. It may thus be important when considering targets for antithrombotic therapy to use multiple animal models with diverse pathways to thrombus formation.

摘要

在缺乏血小板表面糖蛋白VI(GPVI)的FcRγ基因敲除小鼠(FcRγ(-/-))中,研究了胶原受体糖蛋白VI(GPVI)在小动脉血栓形成中的作用。采用重度或轻度FeCl₃损伤诱导血栓形成。与重度FeCl₃损伤相比,轻度损伤时胶原暴露显著延迟且减少。重度损伤后,与野生型小鼠相比,FcRγ(-/-)小鼠初次形成血栓和血管闭塞的时间延迟。与重度损伤相比,轻度损伤后野生型小鼠的血小板聚集减少。然而,FcRγ(-/-)小鼠在重度或轻度损伤后的血小板聚集差异不大。这些数据表明GPVI在FeCl₃诱导的血栓形成中起重要作用。用重组水蛭素预处理野生型小鼠进一步损害了轻度FeCl₃诱导的血栓形成,证明了凝血酶的作用。野生型和FcRγ(-/-)小鼠激光诱导的血栓形成情况相当。激光损伤后未检测到循环血液中有胶原暴露。以血栓大小进行标准化后,激光诱导血栓中的血栓相关组织因子比重度FeCl₃诱导血栓中的高5倍。因此,激光损伤后凝血酶介导的血小板激活似乎比GPVI - 胶原介导的血小板激活更重要。因此,在考虑抗血栓治疗靶点时,使用多种具有不同血栓形成途径的动物模型可能很重要。

相似文献

1
Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo.体内血栓形成的糖蛋白VI依赖性和非依赖性途径。
Blood. 2006 May 15;107(10):3902-6. doi: 10.1182/blood-2005-09-3687. Epub 2006 Feb 2.
2
Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRgamma deficiency.凝血酶克服了与血小板糖蛋白VI/免疫球蛋白γ链(GPVI/FcRγ)缺陷相关的血栓形成缺陷。
Blood. 2006 Jun 1;107(11):4346-53. doi: 10.1182/blood-2005-10-4244. Epub 2006 Jan 3.
3
α2β1 integrin, GPVI receptor, and common FcRγ chain on mouse platelets mediate distinct responses to collagen in models of thrombosis.小鼠血小板上的α2β1整合素、糖蛋白VI(GPVI)受体和共同的FcRγ链在血栓形成模型中介导对胶原蛋白的不同反应。
PLoS One. 2014 Nov 21;9(11):e114035. doi: 10.1371/journal.pone.0114035. eCollection 2014.
4
Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model.在激光损伤模型中,体内凝血酶引发的血小板活化在血栓形成过程中不依赖于血管性血友病因子。
J Clin Invest. 2007 Apr;117(4):953-60. doi: 10.1172/JCI30537. Epub 2007 Mar 22.
5
Complementary roles of glycoprotein VI and alpha2beta1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo.糖蛋白VI和α2β1整合素在体外流动全血中胶原诱导的血栓形成中的互补作用。
FASEB J. 2003 Apr;17(6):685-7. doi: 10.1096/fj.02-0381fje. Epub 2003 Feb 5.
6
Critical role of FcR gamma-chain, LAT, PLCgamma2 and thrombin in arteriolar thrombus formation upon mild, laser-induced endothelial injury in vivo.FcRγ链、LAT、PLCγ2和凝血酶在体内轻度激光诱导的内皮损伤后小动脉血栓形成中的关键作用
Microcirculation. 2008 May;15(4):325-35. doi: 10.1080/10739680701728822.
7
Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.人类动脉粥样硬化斑块通过激活血小板糖蛋白VI刺激血栓形成。
FASEB J. 2005 Jun;19(8):898-909. doi: 10.1096/fj.04-2748com.
8
Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.靶向血小板糖蛋白VI免疫球蛋白样结构域的特罗瓦格勒克斯毒液多肽作为一种新型抗血栓形成剂
Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):1307-1314. doi: 10.1161/ATVBAHA.116.308604. Epub 2017 Jun 8.
9
ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.与糖蛋白VI-Fc融合的ADP酶CD39增强血管病变处的局部抗血栓形成作用。
J Am Heart Assoc. 2017 Jul 27;6(8):e005991. doi: 10.1161/JAHA.117.005991.
10
Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcRgamma chain.小鼠胶原蛋白受体糖蛋白VI的表达和功能严格依赖于其与FcRγ链的结合。
J Biol Chem. 2000 Aug 4;275(31):23998-4002. doi: 10.1074/jbc.M003803200.

引用本文的文献

1
Impaired Secondary Platelet Response in Chronic Kidney Disease as a Consequence of Prior Platelet Activation.慢性肾脏病中继发血小板反应受损是既往血小板激活的结果。
JACC Basic Transl Sci. 2025 Aug 5;10(9):101355. doi: 10.1016/j.jacbts.2025.101355.
2
Reversibly photoswitchable protein assemblies with collagen affinity for in vivo photoacoustic imaging of tumors.具有胶原亲和力的可光致变色蛋白质组装体,可用于肿瘤的体内光声成像。
Sci Adv. 2024 Aug 30;10(35):eadn8274. doi: 10.1126/sciadv.adn8274.
3
Cathelicidin-HG Alleviates Sepsis-Induced Platelet Dysfunction by Inhibiting GPVI-Mediated Platelet Activation.抗菌肽-HG通过抑制糖蛋白VI介导的血小板活化减轻脓毒症诱导的血小板功能障碍。
Research (Wash D C). 2024 Jun 5;7:0381. doi: 10.34133/research.0381. eCollection 2024.
4
Engineering a functional ACL reconstruction graft containing a triphasic enthesis-like structure in bone tunnel for the enhancement of graft-to-bone integration.构建一种功能性前交叉韧带重建移植物,其在骨隧道中包含三相类似止点的结构,以增强移植物与骨的整合。
J Orthop Translat. 2024 Mar 22;45:155-167. doi: 10.1016/j.jot.2024.01.004. eCollection 2024 Mar.
5
Dual antithrombotic therapy dose-dependently alters hemostatic plug structure and function.双联抗栓治疗剂量依赖性地改变止血栓结构和功能。
J Thromb Haemost. 2024 Apr;22(4):1016-1023. doi: 10.1016/j.jtha.2023.12.017. Epub 2023 Dec 23.
6
A thrombus is formed by a gradient of platelet activation and procoagulant endothelium.血栓由血小板活化和促凝内皮形成的梯度所构成。
Res Pract Thromb Haemost. 2023 Sep 21;7(7):102209. doi: 10.1016/j.rpth.2023.102209. eCollection 2023 Oct.
7
Thrombolytic Effects of Philippine Pit Viper (Trimeresurus flavomaculatus) Venom in Human Blood In Vitro and Ferric Chloride-Induced Cardiac Thrombosis on Swiss Webster Mice In Vivo.菲律宾竹叶青蛇(Trimeresurus flavomaculatus)毒液对人血的体外溶栓作用及对瑞士韦伯斯特小鼠体内氯化铁诱导的心脏血栓形成的影响。
Cureus. 2023 Jun 23;15(6):e40856. doi: 10.7759/cureus.40856. eCollection 2023 Jun.
8
Platelet procoagulant membrane dynamics: a key distinction between thrombosis and hemostasis?血小板促凝血膜动力学:血栓形成与止血之间的关键区别?
Blood Adv. 2023 Apr 25;7(8):1615-1619. doi: 10.1182/bloodadvances.2022008122.
9
Modulation of Glycoprotein VI and Its Downstream Signaling Pathways as an Antiplatelet Target.作为抗血小板靶点的糖蛋白 VI 及其下游信号通路的调节。
Int J Mol Sci. 2022 Aug 31;23(17):9882. doi: 10.3390/ijms23179882.
10
Engineering an enthesis-like graft for rotator cuff repair: An approach to fabricate highly biomimetic scaffold capable of zone-specifically releasing stem cell differentiation inducers.工程化用于肩袖修复的类肌腱移植物:一种制造能够区域特异性释放干细胞分化诱导剂的高度仿生支架的方法。
Bioact Mater. 2022 Jan 5;16:451-471. doi: 10.1016/j.bioactmat.2021.12.021. eCollection 2022 Oct.

本文引用的文献

1
Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity.血小板磷脂酶Cγ2信号传导在动脉血栓形成中作为病变严重程度函数的重要性。
Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1293-8. doi: 10.1161/01.ATV.0000163184.02484.69. Epub 2005 Mar 17.
2
Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice.因子IX或因子XI缺乏对小鼠氯化铁诱导的颈动脉闭塞的影响。
J Thromb Haemost. 2005 Apr;3(4):695-702. doi: 10.1111/j.1538-7836.2005.01236.x. Epub 2005 Feb 23.
3
Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice.可溶性糖蛋白VI二聚体与抗糖蛋白VI抗体在小鼠体内的相对抗血栓形成作用。
Blood. 2005 Feb 15;105(4):1492-9. doi: 10.1182/blood-2004-06-2391. Epub 2004 Oct 26.
4
Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation.造血细胞衍生的微粒组织因子在血栓形成过程中促进纤维蛋白的形成。
Blood. 2004 Nov 15;104(10):3190-7. doi: 10.1182/blood-2004-03-0935. Epub 2004 Jul 27.
5
Human platelet glycoprotein VI function is antagonized by monoclonal antibody-derived Fab fragments.人血小板糖蛋白VI的功能被单克隆抗体衍生的Fab片段所拮抗。
J Thromb Haemost. 2003 Dec;1(12):2653-62. doi: 10.1111/j.1538-7836.2003.00495.x.
6
Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.可溶性糖蛋白VI二聚体在体内可抑制血小板与受损血管壁的黏附和聚集。
FASEB J. 2004 Feb;18(2):397-9. doi: 10.1096/fj.03-0464fje. Epub 2003 Dec 4.
7
Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels.体内动脉血栓形成过程中血小板的初始聚集受到基础环磷酸腺苷(cAMP)水平升高的抑制。
Blood. 2004 Mar 15;103(6):2127-34. doi: 10.1182/blood-2003-04-1133. Epub 2003 Nov 26.
8
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.组织因子在体内发展中的血栓内的积累取决于微粒P-选择素糖蛋白配体1和血小板P-选择素。
J Exp Med. 2003 Jun 2;197(11):1585-98. doi: 10.1084/jem.20021868.
9
The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion.通过靶向基因缺失阐明糖蛋白VI对稳定血小板黏附和血栓形成的作用。
Blood. 2003 Sep 1;102(5):1701-7. doi: 10.1182/blood-2003-03-0717. Epub 2003 May 8.
10
Targeting of the collagen-binding site on glycoprotein VI is not essential for in vivo depletion of the receptor.靶向糖蛋白VI上的胶原蛋白结合位点对于该受体的体内清除并非必不可少。
Blood. 2003 May 15;101(10):3948-52. doi: 10.1182/blood-2002-10-3242. Epub 2003 Jan 16.